Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
主要组织相容性复合体II类和程序性死亡配体1表达可预测经典霍奇金淋巴瘤中程序性死亡受体1阻断后的预后
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2017.77.3994
Roemer, Margaretha G M; Redd, Robert A; Cader, Fathima Zumla; Pak, Christine J; Abdelrahman, Sara; Ouyang, Jing; Sasse, Stephanie; Younes, Anas; Fanale, Michelle; Santoro, Armando; Zinzani, Pier Luigi; Timmerman, John; Collins, Graham P; Ramchandren, Radhakrishnan; Cohen, Jonathon B; De Boer, Jan Paul; Kuruvilla, John; Savage, Kerry J; Trneny, Marek; Ansell, Stephen; Kato, Kazunobu; Farsaci, Benedetto; Sumbul, Anne; Armand, Philippe; Neuberg, Donna S; Pinkus, Geraldine S; Ligon, Azra H; Rodig, Scott J; Shipp, Margaret A